0ROG Stock Overview
Operates as a healthcare service provider in Switzerland and internationally. More details
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 2/6 |
Past Performance | 4/6 |
Financial Health | 6/6 |
Dividends | 3/6 |
Rewards
Risk Analysis
No risks detected for 0ROG from our risk checks.
My Notes
Capture your thoughts, links and company narrative
Galenica AG Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CHF 73.40 |
52 Week High | CHF 78.10 |
52 Week Low | CHF 69.30 |
Beta | 0.19 |
1 Month Change | -4.05% |
3 Month Change | -2.46% |
1 Year Change | 1.38% |
3 Year Change | 6.48% |
5 Year Change | 22.64% |
Change since IPO | 70.78% |
Recent News & Updates
Recent updates
Shareholder Returns
0ROG | GB Healthcare | GB Market | |
---|---|---|---|
7D | 0.8% | -1.0% | -0.6% |
1Y | 1.4% | -25.4% | 2.7% |
Return vs Industry: 0ROG exceeded the UK Healthcare industry which returned -25.9% over the past year.
Return vs Market: 0ROG underperformed the UK Market which returned 3.1% over the past year.
Price Volatility
0ROG volatility | |
---|---|
0ROG Average Weekly Movement | 1.8% |
Healthcare Industry Average Movement | 5.0% |
Market Average Movement | 4.8% |
10% most volatile stocks in GB Market | 10.5% |
10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0ROG has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: 0ROG's weekly volatility (2%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1927 | 7,955 | Marc Werner | www.galenica.com |
Galenica AG operates as a healthcare service provider in Switzerland and internationally. It operates through two segments, Products & Care, and Logistics & IT. The Products & Care segment operates pharmacies and partner pharmacies under the Amavita, Sun Store, and Coop Vitality brands.
Galenica AG Fundamentals Summary
0ROG fundamental statistics | |
---|---|
Market cap | CHF 3.67b |
Earnings (TTM) | CHF 169.68m |
Revenue (TTM) | CHF 3.80b |
21.6x
P/E Ratio1.0x
P/S RatioIs 0ROG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
0ROG income statement (TTM) | |
---|---|
Revenue | CHF 3.80b |
Cost of Revenue | CHF 3.34b |
Gross Profit | CHF 464.58m |
Other Expenses | CHF 294.90m |
Earnings | CHF 169.68m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Mar 11, 2025
Earnings per share (EPS) | 3.41 |
Gross Margin | 12.22% |
Net Profit Margin | 4.46% |
Debt/Equity Ratio | 42.9% |
How did 0ROG perform over the long term?
See historical performance and comparisonDividends
3.0%
Current Dividend Yield65%
Payout RatioCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/26 22:40 |
End of Day Share Price | 2024/12/23 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Galenica AG is covered by 12 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Bruno Bulic | Baader Helvea Equity Research |
Volker Bosse | Baader Helvea Equity Research |
Alexander Berglund | BofA Global Research |